Gotham Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,391
| Closed | -$400K | – | 1354 |
|
|
2023
Q3 | $400K | Buy |
+19,391
| New | +$400K | 0.01% | 1031 |
|
|
2023
Q1 | – | Sell |
-13,029
| Closed | -$362K | – | 1340 |
|
|
2022
Q4 | $362K | Sell |
13,029
-1,578
| -11% | -$43.9K | 0.01% | 993 |
|
|
2022
Q3 | $448K | Sell |
14,607
-678
| -4% | -$20.8K | 0.01% | 874 |
|
|
2022
Q2 | $450K | Buy |
+15,285
| New | +$450K | 0.01% | 816 |
|
|
2021
Q4 | – | Sell |
-5,317
| Closed | -$268K | – | 1157 |
|
|
2021
Q3 | $268K | Sell |
5,317
-4,222
| -44% | -$213K | 0.01% | 878 |
|
|
2021
Q2 | $748K | Sell |
9,539
-15,702
| -62% | -$1.23M | 0.03% | 572 |
|
|
2021
Q1 | $1.44M | Buy |
25,241
+17,646
| +232% | +$1.01M | 0.06% | 367 |
|
|
2020
Q4 | $636K | Buy |
+7,595
| New | +$636K | 0.02% | 659 |
|